Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors

Pagano, 2006, The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study, Haematologica, 91, 1068 Imhof, 2004, Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole, Clin Infect Dis, 39, 743, 10.1086/423274 Malani, 2007, Changing epidemiology of rare mold infections: implications for therapy, Drugs, 67, 1803, 10.2165/00003495-200767130-00001 Trifilio, 2007, Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole, Bone Marrow Transplant, 40, 451, 10.1038/sj.bmt.1705754 Brown, 2005, Zygomycosis: an emerging fungal infection, Am J Health Syst Pharm, 62, 2593, 10.2146/ajhp050188 Chayakulkeeree, 2006, Zygomycosis: the re-emerging fungal infection, Eur J Clin Microbiol Infect Dis, 25, 215, 10.1007/s10096-006-0107-1 Ameen, 2007, The emergence of mucormycosis as an important opportunistic fungal infection: five cases presenting to a tertiary referral center for mycology, Int J Dermatol, 46, 380, 10.1111/j.1365-4632.2007.03057.x Ustun, 2007, Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation, Bone Marrow Transplant, 39, 807, 10.1038/sj.bmt.1705679 Trifilio, 2007, Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy, Bone Marrow Transplant, 39, 425, 10.1038/sj.bmt.1705614 Torres-Narbona, 2008, Workload and clinical significance of the isolation of zygomycetes in a tertiary general hospital, Med Mycol, 46, 225, 10.1080/13693780701796973 Kontoyiannis, 2005, Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case–control observational study of 27 recent cases, J Infect Dis, 191, 1350, 10.1086/428780 Suzuki, 2009, Breakthrough disseminated zygomycosis induced massive gastrointestinal bleeding in a patient with acute myeloid leukemia receiving micafungin, J Infect Chemother, 15, 42, 10.1007/s10156-008-0657-5 Girmenia, 2005, Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation, J Clin Microbiol, 43, 5395, 10.1128/JCM.43.10.5395-5396.2005 Lamaris, 2009, Increased virulence of zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis, J Infect Dis, 199, 1399, 10.1086/597615 Shpitzer, 2005, Seasonal variations in rhino-cerebral Mucor infection, Ann Otol Rhinol Laryngol, 114, 695, 10.1177/000348940511400907 Al-Ajam, 2006, Mucormycosis in the Eastern Mediterranean: a seasonal disease, Epidemiol Infect, 134, 341, 10.1017/S0950268805004930 Rogers, 2008, Treatment of zygomycosis: current and new options, J Antimicrob Chemother, 61, i35, 10.1093/jac/dkm429 Kauffman, 2007, Zygomycosis: an emerging fungal infection with new options for management, Curr Infect Dis Rep, 9, 435, 10.1007/s11908-007-0066-4 Peel, 2008, Posaconazole as first line treatment for disseminated zygomycosis, Mycoses, 51, 542, 10.1111/j.1439-0507.2008.01499.x Cornely, 2007, Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia, N Engl J Med, 356, 348, 10.1056/NEJMoa061094 Ullmann, 2007, Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease, N Engl J Med, 356, 335, 10.1056/NEJMoa061098 Gonzalez, 2008, Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: point, J Natl Compr Canc Netw, 6, 175, 10.6004/jnccn.2008.0014 Maertens, 2007, Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies, Eur J Haematol, 78, 275, 10.1111/j.1600-0609.2006.00805.x Grigg, 2008, Minimizing the risk of recurrent or progressive invasive mold infections during stem cell transplantation or further intensive chemotherapy, Transpl Infect Dis, 10, 3, 10.1111/j.1399-3062.2007.00259.x